Insurance capital is making further significant inroads into the private equity landscape. On September 7th, Dajia Life Insurance Co., Ltd. announced that on August 25th, it had signed an agreement as a limited partner (LP) with Yuance Gongchuang Capital Management Co., Ltd. and other partners to invest in the Yuance Zhuoheng Relay Equity Investment (Yixing) Partnership Enterprise, a fund initiated by Yuance Capital.
Throughout 2024, insurance funds have been increasingly active as limited partners in private equity funds, seeking cross-cycle investment returns through allocations to income-generating assets such as income-producing real estate and infrastructure, as well as growth assets in the hard technology sector. Industry insiders point to a confluence of policy liberalization and yield anxieties as the primary drivers behind the sustained capital commitments from insurers in recent years. Compared to previous cycles, the current wave of private equity investing by insurers is characterized by greater focus, proactiveness, and a more systematic approach, with a notable trend being the use of innovative vehicles like S funds to recycle existing investments and alleviate the backlog in private equity exits.
According to public information, the Yuance Zhuoheng Fund operates as a limited partnership private equity vehicle. Dajia Life is the largest subscriber with a capital commitment of 980 million yuan, representing 67.59% of the fund's total. Other partners include Yixing New Kinetic Energy Industry Fund Partnership Enterprise, which committed 300 million yuan; Guogai Juying Phase I (Fuzhou) Equity Investment Partnership, committing 100 million yuan; Fuzhou Rongtou Industrial Development Investment Fund Partnership, committing 50 million yuan; and Yuance Gongchuang Capital Management Co., Ltd. itself, which committed 20 million yuan. Total capital commitments for the fund stand at 1.45 billion yuan. Managed by Yuance Capital, the fund focuses on acquiring interests in quality private equity funds managed by market-oriented investment institutions, along with a small allocation to special opportunity equity projects, with a sector focus on hard technology and advanced manufacturing, healthcare, consumer supply chains, and carbon neutrality.
The recent trend also includes a rise in insurers forming consortiums to back private equity funds. For instance, the Tianjin Jiayu Equity Investment Fund Partnership, established in 2025 with a total scale of 4.5 billion yuan, counts Dajia Life, AIA Life, BOC-Samsung Life, Manulife-Sinochem Life, and Pramerica Fosun Life among its partners, targeting long-term rental apartment investments. Another example is the Tianjin Lanqin Equity Investment Partnership, established in 2026 with an 8.6 billion yuan scale, where Taikang Life, Great Wall Life, AIA Life, Manulife-Sinochem Life, Generali China Life, MetLife, and Taikang Pension have joined forces to invest in commercial real estate.
"The persistent involvement of insurance funds as LPs in private equity funds in recent years stems from a long-term evolution involving both the liability-side characteristics of insurers and the external market environment," said Yuan Shuai, deputy director of the Investment Department at the China Urban Development Research Institute. He explained that the inherent nature of insurance funds demands assets with strong duration matching, stable returns, and cross-cycle resilience. Historically, standard fixed-income assets sufficed to cover liabilities, but that environment is shifting. The supply of high-quality assets that match long durations and provide stable cash flow under traditional frameworks is narrowing, and relying solely on public equity and fixed-income portfolios makes it difficult to hedge against the pressure of long-term interest rate declines. This challenge is compounded by the increasing volatility of public market equities. Therefore, insurers are seeking allocation vehicles that can extend asset duration and smooth income curves across cycles, a need that private equity funds are well-positioned to fulfill.
This new phase of investing is a departure from earlier, more tentative forays. Insurance funds are now elevating private equity allocations to a strategic component within their broader asset allocation frameworks. Investment directions are more aligned with real assets that match their liability durations, and commitment pacing is more deliberate, calibrated against liability maturity structures and cash flow projections to ensure a two-way fit between capital deployment and fund investment-exit cycles, minimizing the risk of idle capital or cash flow mismatches.
An analysis of recent activity reveals a maturing of insurer participation models. Some insurers have progressed from solely being LPs in direct private equity funds to engaging with S funds, transitioning from a purely financial sponsor role to one that encompasses both "LP+GP" functions. For example, China Life, in partnership with relevant entities in Fujian Province, helped establish the Fujian Xinrui Kechuang Relay Fund, one of China's larger blind pool S funds. The fund has a total scale exceeding 4 billion yuan and is managed by Guoshi Jinshi.
"Looking ahead, the pace of insurers deploying capital as LPs in private equity is likely to be steady and progressive. While there is still room for allocation ratios to increase, growth will be more rational, hinging on the alignment between regulatory policy and market opportunities," said Gao Chengyuan, president of Tiaoyuan Influence Research Institute. He identified three areas that will continue to attract long-term insurer investment: the hard technology sector centered on AI and AI+, viewed as a core investment theme for the next decade; the healthcare and eldercare industry, which benefits from synergies with the insurance main business; and new infrastructure and prime city real estate that offer stable cash flows.
Yuan Shuai added that the overall pace of insurer LP allocations in private equity will likely avoid short-term surges, instead maintaining a steady and upward expansion. The headroom for higher allocation ratios remains, driven by a persistent gap between insurer allocation needs and the supply of quality long-duration assets, with balance sheet management demands continuing to fuel this expansion.
From a segmented perspective, industry observers anticipate distinct development paths for large and small insurers, creating a landscape characterized by "large players leading, smaller ones focusing". Leading insurers, leveraging their capital strength, research capabilities, and licensed private equity manager status, are expected to extend their roles from pure LPs to "LP+GP" dual roles. They will likely take the lead in establishing large-scale, multi-billion-yuan industrial funds and implement systems such as GP whitelists to foster collaboration with top-tier managers, achieving both proprietary investment and an ecosystem-driven approach. Conversely, smaller insurers are more inclined towards a "differentiated focus" strategy. Given their resource constraints, they may either participate in regional funds leveraging local connections or concentrate on niche sectors like healthcare and green energy, forming a competitive positioning through partnerships with specialized general partners.